Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence

Francesco Montorsi, Giorgio Guazzoni, Franco Bergamaschi, Alessandro Dodesini, Patrizio Rigatti, Giuliano Pizzini, Alberto Miani

Research output: Contribution to journalArticlepeer-review


A four-drug vasoactive mixture (papaverine hydrochloride, prostaglandin E1, phentolamine mesylate, atropine sulfate) was used for intracavernous injection therapy in 94 patients with vasculogenic impotence as diagnosed by color Doppler sonography and dynamic infusion cavernosometry-cavernosography. At a mean follow-up of twenty months, 66 patients (70%) are using the injections with the initial dose and are satisfied; 14 patients (15%) are using the injections with a smaller dose than initially given; and 14 patients (15%) dropped intracavernous treatment. Only 4 patients (4%) were unable to achieve a sustained rigid erection during the mixture titration phase. Selected cases of vasculogenic impotence can be safely and effectively treated by the association of drugs which rely on different mechanisms of action, producing a pharmacologic synergism which enhances the overall therapeutic effect.

Original languageEnglish
Pages (from-to)554-558
Number of pages5
Issue number5
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence'. Together they form a unique fingerprint.

Cite this